Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Nebulised antibiotics vs IV antibiotics Quality of life · people with cystic fibrosis experiencing a pulmonary exacerbation Intravenous antibiotics for pulmonary exacerbations in people with cystic fibrosis (2015) · Cochrane | no estimate extracted | NR | No studies |
Decision aids for informed consent vs standard informed consent Accurate risk perception · people considering taking part in clinical trials Decision aids for people considering taking part in clinical trials (2015) · Cochrane | no estimate extracted | NR | No studies |
Decision aids for informed consent vs standard informed consent Values based decision · people considering taking part in clinical trials Decision aids for people considering taking part in clinical trials (2015) · Cochrane | no estimate extracted | NR | No studies |
Decision aids for informed consent vs standard informed consent Recognition that a decision needs to be made · people considering taking part in clinical trials Decision aids for people considering taking part in clinical trials (2015) · Cochrane | no estimate extracted | NR | No studies |
Decision aids for informed consent vs standard informed consent Involvement in decision · people considering taking part in clinical trials Decision aids for people considering taking part in clinical trials (2015) · Cochrane | no estimate extracted | NR | No studies |
Leukoreduced PRBCs vs non‐leukoreduced PRBCs Non‐infectious complication · Patients receiving RBC transfusion Leukoreduction for the prevention of adverse reactions from allogeneic blood transfusion (2015) · Cochrane | no estimate extracted | NR | No studies |
Adjunct cognitive behavioural therapy vs adjunct supportive psychotherapy Global state: Clinically significant improvement · patients with delusional disorder Treatments for delusional disorder (2015) · Cochrane | no estimate extracted | NR | No studies |
Adjunct cognitive behavioural therapy vs adjunct supportive psychotherapy Mental state: Delusions ‐ clinically significant improvement · patients with delusional disorder Treatments for delusional disorder (2015) · Cochrane | no estimate extracted | NR | No studies |
Adjunct cognitive behavioural therapy vs adjunct supportive psychotherapy Service use: Admission · patients with delusional disorder Treatments for delusional disorder (2015) · Cochrane | no estimate extracted | NR | No studies |
MET vs sham MET CI: confidence interval · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET vs all other therapies General well‐being · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET vs all other therapies Adverse events · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET vs all other therapies CI: confidence interval · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET vs all other therapies General well‐being · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET vs all other therapies Adverse events · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET vs all other therapies CI: confidence interval · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET plus any intervention vs that same intervention alone General well‐being · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET plus any intervention vs that same intervention alone Adverse events · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET plus any intervention vs that same intervention alone CI: confidence interval · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET plus any intervention vs that same intervention alone General well‐being · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET plus any intervention vs that same intervention alone Adverse events · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET plus any intervention vs other therapies plus that intervention General well‐being · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET plus any intervention vs that same intervention alone CI: confidence interval · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET plus any intervention vs other therapies plus that intervention General well‐being · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET plus any intervention vs other therapies plus that intervention Adverse events · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET plus any intervention vs other therapies plus that intervention CI: confidence interval · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET plus any intervention vs other therapies plus that intervention Adverse events · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET plus any intervention vs other therapies plus that intervention CI: confidence interval · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET vs sham MET Functional status · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET vs sham MET General well‐being · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
MET vs sham MET Adverse events · patients with non‐specific low‐back pain (LBP) Muscle energy technique for non‐specific low‐back pain (2015) · Cochrane | no estimate extracted | NR | No studies |
TDC vs medical therapy CI: Confidence interval;HR: hazard ratio · people with patent foramen ovale and a history of cryptogenic stroke or transient ischemic attack Closure versus medical therapy for preventing recurrent stroke in patients with patent foramen ovale and a… (2015) · Cochrane | no estimate extracted | NR | No studies |
Gabapentin vs placebo Number of patients with self reported pain relief of 50% or greater (not measured) · patients with pain in Guillain‐Barré syndrome Pharmacological treatment for pain in Guillain‐Barré syndrome (2015) · Cochrane | no estimate extracted | NR | No studies |
Methylprednisolone vs placebo Number of patients with self reported pain relief of 50% or greater (not measured) · patients with Guillain‐Barré syndrome, with varying severities of pain Pharmacological treatment for pain in Guillain‐Barré syndrome (2015) · Cochrane | no estimate extracted | NR | No studies |
Gabapentin vs carbamazepine Number of patients with self reported pain relief of 50% or greater (not measured) · intensive care unit in India Pharmacological treatment for pain in Guillain‐Barré syndrome (2015) · Cochrane | no estimate extracted | NR | No studies |
Carbamazepine vs placebo Number of patients with self reported pain relief of 50% or greater (not measured) · patients with pain in Guillain‐Barré syndrome Pharmacological treatment for pain in Guillain‐Barré syndrome (2015) · Cochrane | no estimate extracted | NR | No studies |
L‐acetylcarnitine vs placebo Outcomes: Behaviour or social performance · people being treated for fragile X syndrome L‐acetylcarnitine for treating fragile X syndrome (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Participants with a serious adverse event · adults with moderate or severe acute postoperative pain Single dose oral ibuprofen plus codeine for acute postoperative pain in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Deaths · adults with moderate or severe acute postoperative pain Single dose oral ibuprofen plus codeine for acute postoperative pain in adults (2015) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table 1: comparison of operation types: early results of needle fasciotomy vs limited fasciectomy Outcomesa · 125 hands in 121 participants with Dupuytren's disease of the fingers for early outcomes (van Rijssen 2006) Surgery for Dupuytren's contracture of the fingers (2015) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table 2: comparison of operation types: late results of needle fasciotomy vs limited fasciectomy Major outcome group 5 (adverse effects)d · 93 participants (van Rijssen 2012a) Surgery for Dupuytren's contracture of the fingers (2015) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table 3: comparison of operation types: firebreak skin grafting vs z‐plasty closure of fasciectomy Major outcome group 2 (patient satisfaction and other PROM) · 79 participants (Ullah 2009) Surgery for Dupuytren's contracture of the fingers (2015) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table 4: refining rehabilitation: three months of postoperative night splinting with hand therapy vs hand therapy alone Major outcome group 2 (patient satisfaction) · 210 participants with Dupuytren's disease of the fingers in 2 studies (225 digits reported across all studies) (Collis… Surgery for Dupuytren's contracture of the fingers (2015) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table 4: refining rehabilitation: three months of postoperative night splinting with hand therapy vs hand therapy alone Major outcome group 4 (recurrence) · 210 participants with Dupuytren's disease of the fingers in 2 studies (225 digits reported across all studies) (Collis… Surgery for Dupuytren's contracture of the fingers (2015) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table 1: comparison of operation types: early results of needle fasciotomy vs limited fasciectomy Major outcome group 4 (recurrence) · 125 hands in 121 participants with Dupuytren's disease of the fingers for early outcomes (van Rijssen 2006) Surgery for Dupuytren's contracture of the fingers (2015) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table 2: comparison of operation types: late results of needle fasciotomy vs limited fasciectomy DASH hand function score at 5 years Major outcome group 1 (hand function) (scores between 0 and 100, where 0 represents no impairment in hand function and 100 represents maximum impairment in hand function) · 93 participants (van Rijssen 2012a) Surgery for Dupuytren's contracture of the fingers (2015) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table 2: comparison of operation types: late results of needle fasciotomy vs limited fasciectomy Major outcome group 3 (early angular outcome)b · 93 participants (van Rijssen 2012a) Surgery for Dupuytren's contracture of the fingers (2015) · Cochrane | no estimate extracted | NR | No studies |
Dalteparin vs placebo Pain duration ‐ not measured · patients with people with sickle cell disease Low‐molecular‐weight heparins for managing vaso‐occlusive crises in people with sickle cell disease (2015) · Cochrane | no estimate extracted | NR | No studies |
Dalteparin vs placebo The requirement for opiate treatment ‐ not measured · patients with people with sickle cell disease Low‐molecular‐weight heparins for managing vaso‐occlusive crises in people with sickle cell disease (2015) · Cochrane | no estimate extracted | NR | No studies |
Dalteparin vs placebo Number of serious complications of SCD ‐ not measured · patients with people with sickle cell disease Low‐molecular‐weight heparins for managing vaso‐occlusive crises in people with sickle cell disease (2015) · Cochrane | no estimate extracted | NR | No studies |